These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14110659)

  • 1. ANTIHEPARIN AND ANTIFIBRINOLYTIC ACTIVITY OF BLOOD IN PATIENTS WITH ATHEROSCLEROSIS.
    MYASNIKOV AL; CHAZOV EI
    Am Heart J; 1964 Jan; 67():18-22. PubMed ID: 14110659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiheparin and antifibrinolytic activity of the blood in atherosclerotic patients].
    CHAZOV EI
    Ter Arkh; 1962 Oct; 34():36-40. PubMed ID: 14020453
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems in atherosclerosis, hypertension, myocardial infarct and thrombosis in light of the theory of the functional role of the anticoagulation system].
    Kalishevskaia TM
    Patol Fiziol Eksp Ter; 1982; (2):82-6. PubMed ID: 6211649
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE ARTERIOSCLEROSIS PROBLEM].
    ANSCHUETZ F
    Wien Med Wochenschr; 1964 Feb; 114():115-8. PubMed ID: 14136168
    [No Abstract]   [Full Text] [Related]  

  • 5. [COMBINED FIBRINOLYSIN AND HEPARIN THERAPY OF VASCULAR THROMBOSIS].
    MIASNIKOV AL; KUDRIASHOV BA; CHASOV EI; ANDREENKO GV
    Kardiologiia; 1964; 4():3-8. PubMed ID: 14152588
    [No Abstract]   [Full Text] [Related]  

  • 6. [EXPERIENCE IN THE CLINICAL USE OF FIBRINOLYSIN].
    PANCHENKO VM; ANDREENKO GV
    Ter Arkh; 1964 Jan; 36():43-51. PubMed ID: 14149444
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protective effect of combined injection of fibrinolysin and heparin against thrombogenesis in animals during the pre-thrombotic state and in experimental atherosclerosis].
    Andreenko GV; Bazaz'ian GG; Sytina NP
    Biull Eksp Biol Med; 1965 Jul; 60(7):31-4. PubMed ID: 4222542
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of fibrinolysin with heparin and thrombolytin on blood coagulation indices in myocardial infarct patients with thromboembolic complications].
    Panchenko VM; Dmitrieva ZA; Pastorova VE
    Ter Arkh; 1971 Aug; 43(8):95-9. PubMed ID: 4261359
    [No Abstract]   [Full Text] [Related]  

  • 9. [EARLY ARTERIAL CHANGES IN EXPERIMENTAL ATHEROSCLEROSIS IN MONKEYS].
    CHAZOV EI; USHKALOV AF; KLEMBOVSKII AI; BYKOVSKOI KN
    Arkh Patol; 1963; 25():29-37. PubMed ID: 14147685
    [No Abstract]   [Full Text] [Related]  

  • 10. ATHEROSCLEROSIS AND THROMBOSIS.
    NAHUM LH
    Conn Med; 1964 Sep; 28():645-6. PubMed ID: 14201314
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE TREATMENT OF VENOUS THROMBOSIS].
    APARICIO
    J Med Bord; 1964 Mar; 141():443-4. PubMed ID: 14143016
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708
    [No Abstract]   [Full Text] [Related]  

  • 13. OBSERVATIONS CONCERNING INTRACEREBRAL VASCULAR OCCLUSIONS.
    ZATZ LM; IANNONE AM; ECKMAN PB; HECKER SP
    Neurology; 1965 Apr; 15():389-401. PubMed ID: 14280604
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperlipoproteinemia as the cause of increased plasma antiheparin activity in patients with arteriosclerosis].
    Rółkowski R; Worowski K; Skrzydlewski Z; Głowiński S
    Kardiol Pol; 1986; 29(3):204-8. PubMed ID: 3773409
    [No Abstract]   [Full Text] [Related]  

  • 16. ENZYME THERAPY FOR CORONARY ARTERY DISEASE.
    PETTERSSON T
    Geriatrics; 1964 Feb; 19():104-9. PubMed ID: 14124951
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of the fibrinolytic inhibitor from peanuts on the process of hypercholesterolic atherogenesis].
    COCCHERI S; LORETI A; GENNARI P; BEGHELLI V
    Boll Soc Ital Biol Sper; 1962 Jan; 38():64-7. PubMed ID: 13880058
    [No Abstract]   [Full Text] [Related]  

  • 18. Have the platelet antiheparin and antiplasmin activities the same support?
    Moriau M
    Thromb Diath Haemorrh; 1969 Nov; 22(2):403-7. PubMed ID: 4245336
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboplastic, fibrinolytic and antiheparin activity of pancreatic tissue in acute experimental pancreatitis.
    Gabryelewicz A; Worowski K; Prokopowicz J; Rejniak L
    Bull Acad Pol Sci Biol; 1972; 20(9):691-4. PubMed ID: 4263956
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of fibrinolysin and heparin on the kinetic properties of the thrombocytes and the oxidation-reduction processes in myocardial infarct].
    Orlova NP; Volodin EE; Lokhvitskaia NL
    Kardiologiia; 1978 Jan; 18(1):115-8. PubMed ID: 146757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.